{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-014640","form_type":"8-K","ticker":"ARDT","cik":"0001756655","company_name":"Ardent Health, Inc.","filed_at":"2026-03-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.086558+00:00","generated_at":"2026-05-15T21:44:55.442971+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Ardent Health Q4 adj EBITDA down 26.6% to $134M; 2026 guidance issued","bullets":["Q4 total revenue $1.605B (flat YoY); net income $45M vs $114M prior year.","Q4 adjusted EBITDA $134M (down 26.6% YoY) due to annualization of prior-year benefits.","Full-year 2025 revenue $6.32B (+6%); adjusted EBITDA $545M (+9.3%); margin +20bps to 8.6%.","2026 guidance: revenue $6.4B-$6.7B, adjusted EBITDA $485M-$535M, reflecting headwinds.","Net leverage improved to 0.8x; operating cash flow $471M (+49% YoY); share buyback $3M in Q4."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-014640","json":"https://secwatch.observer/filing/0001628280-26-014640.json","markdown":"https://secwatch.observer/filing/0001628280-26-014640.md","text":"https://secwatch.observer/filing/0001628280-26-014640.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1756655/000162828026014640/0001628280-26-014640-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1756655/000162828026014640/ardt-20260304.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T21:44:55.442971+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"51b85e7228f5008dea45d3811fc97612cbb653e6","claim":"Ardent Health, Inc. reported the quarter ended December 31, 2025 results: revenue $1,605 million, net income $45 million, EPS $0.32 per diluted share. Guidance initiated.","evidence_excerpt":"See the footnotes to the Operating Statistics table of this press release for definitions of the metrics below and a full list of key operating metrics. Total Revenue 4Q25 : $1.61 billion 2025 : $6.32 billion ; 6.0% growth Y/Y Net Income Attributable to Ardent Health 4Q25 : $45 million Adjusted EBITDA (1) 4Q25 : $134 million 2025 : $545 million ; 9.3% growth Y/Y","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1756655/000162828026014640/0001628280-26-014640-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended December 31, 2025"},{"label":"Revenue","value":"$1,605 million"},{"label":"Net income","value":"$45 million"},{"label":"EPS","value":"$0.32 per diluted share"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}